In particular, HDAC6 inhibitor has a substantial advantage in the treatment of sepsis.135 The selective inhibition can significantly reduce levels of proinflammatory mediators, inhibit macrophage apoptosis, promote bacterial clearance, increase immune cell phagocytosis, and improve survival in a lethal murine model of sepsis. Here, HDAC6 is linked to Sepsis.